Inspire Medical Systems, Inc. (INSP)

Market Cap	3.98B
Revenue (ttm)	882.62M
Net Income (ttm)	44.56M
Shares Out	29.06M
EPS (ttm)	1.48
PE Ratio	92.68
Forward PE	83.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,033,090
Open	140.28
Previous Close	140.03
Day's Range	136.48 - 142.26
52-Week Range	70.77 - 216.01
Beta	0.70
Analysts	Buy
Price Target	127.07 (-7.12%)
Earnings Date	Nov 3, 2025

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The comp...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 3, 2018
• Employees: 1,246
• Stock Exchange: NYSE
• Ticker Symbol: INSP
• Website: https://www.inspiresleep.com

Analyst Forecast

According to 15 analysts, the average rating for INSP stock is "Buy." The 12-month stock price target is $127.07, which is a decrease of -7.12% from the latest price.

Price Target

$127.07

(-7.12% downside)

Analyst Consensus: Buy